Somatostatin receptor scintigraphy as a potential diagnostic and treatment modality for thyroid follicular-cell-derived cancers

Thyroid

Volumn 20, Issue 6, 2010, Pages 671-672

  Margulies, Debra J ^a   Blum, Manfred ^b  

^a LENOX HILL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; GALLIUM 68; IODINE 131; PASIREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; SYNAPTOPHYSIN; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; INDIUM-111-OCTREOTIDE; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT;

AGED; APPENDIX CANCER; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENZYME ACTIVITY; HASHIMOTO DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LIGAND BINDING; MALE; PRIORITY JOURNAL; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; SCINTISCANNING; THYROID NEOPLASMS;

AGED; HUMANS; MALE; OCTREOTIDE; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; THYROID NEOPLASMS;

EID: 77953948908     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0453     Document Type: Letter

References (4)

1. Lincke T, Singer J, Kluge R, Sabri O, Paschke R 2009 Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid 19:381-389.
2. Garin E, Devillers A, Le Cloirec J, Bernard AM, Lescouarc'h J, Herry JY, Reubi JC, Bourguet P 1998 Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Eur J Nucl Med 25:687-694.
3. Jaap J, Teunissen, Kwekkeboom D, Krenning E 2008 Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatosatin analogs. Trends Endocrinol Metab 17:19-25.
4. Görges R, Kahaly G, Müller-Brand J, Mäcke H, Roser HW, Bockisch A 2001 Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer. Thyroid 11:647-659.